Patents by Inventor Minjung HONG

Minjung HONG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230285400
    Abstract: Provided herein are pharmaceutical compositions (e.g., oral dosage formulations) comprising (S)-2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione, or an enantiomer, mixture of enantiomers, tautomer, isotopolog, or pharmaceutically acceptable salt thereof, and a carrier or diluent. Also provided herein are methods of preparing and methods of using the pharmaceutical compositions.
    Type: Application
    Filed: November 7, 2022
    Publication date: September 14, 2023
    Inventors: Sreenivas S. Bhat, Fabien Boulineau, Donna Carroll, Tracy Lee Gaebele, Yuchuan Gong, Isabel Minjung Hong, Zhengmao Li, Ye Tian
  • Patent number: 11504378
    Abstract: Provided herein are pharmaceutical compositions (e.g., oral dosage formulations) comprising (S)-2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione, or an enantiomer, mixture of enantiomers, tautomer, isotopolog, or pharmaceutically acceptable salt thereof, and a carrier or diluent. Also provided herein are methods of preparing and methods of using the pharmaceutical compositions.
    Type: Grant
    Filed: October 20, 2020
    Date of Patent: November 22, 2022
    Assignee: CELGENE CORPORATION
    Inventors: Sreenivas S. Bhat, Fabien Boulineau, Donna Carroll, Tracy Lee Gaebele, Yuchuan Gong, Isabel Minjung Hong, Zhengmao Li, Ye Tian
  • Publication number: 20210113575
    Abstract: Provided herein are pharmaceutical compositions (e.g., oral dosage formulations) comprising (S)-2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione, or an enantiomer, mixture of enantiomers, tautomer, isotopolog, or pharmaceutically acceptable salt thereof, and a carrier or diluent. Also provided herein are methods of preparing and methods of using the pharmaceutical compositions.
    Type: Application
    Filed: October 20, 2020
    Publication date: April 22, 2021
    Inventors: Sreenivas S. Bhat, Fabien Boulineau, Donna Carroll, Tracy Lee Gaebele, Yuchuan Gong, Isabel Minjung Hong, Zhengmao Li, Ye Tian
  • Publication number: 20180243192
    Abstract: The present specification relates to a moldable solid preparation hair care composition containing a cationic surfactant, an anionic surfactant and a thickener, wherein the amount of cationic surfactant is 0.1-5 wt % on the basis of the total composition, the amount of anionic surfactant is greater than or equal to 0.1 wt % and less than 1 wt % on the basis of the total composition, and the amount of thickener is 0.1-15 wt % on the basis of the total composition. According to one aspect of the present invention, the hair care composition has excellent moldability as a solid preparation and, simultaneously, exhibits remarkable conditioning effects.
    Type: Application
    Filed: September 20, 2016
    Publication date: August 30, 2018
    Applicant: AMOREPACIFIC CORPORATION
    Inventors: Yoon Kyun HWANG, Sung Ah BIN, Minjung HONG, Kyungmi LEE, Jang Won CHOI